norethindrone has been researched along with Coronary Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jespersen, J; Schwarz, H; Sidelmann, JJ; Skouby, SO; Vitzthum, F | 1 |
| Graff-Iversen, S; Hammar, N; Thelle, DS; Tonstad, S | 1 |
| Honkanen, R; Kröger, H; Pentti, K; Saarikoski, S; Sandini, L; Tuppurainen, MT | 1 |
| Collins, P; Flather, M; Lees, B; Mister, R; Proudler, AJ; Stevenson, JC | 1 |
| Blumenthal, JA; Bower, JK; Hinderliter, AL; McFetridge-Durdle, J; Newby, LK; Sherwood, A | 1 |
| Clark, DM; Farish, E; Fletcher, CD; Hart, DM; Kitchener, H; Leggate, J; Sharpe, GL | 1 |
| Christiansen, C; Rødbro, P | 1 |
| Meade, TW | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Stocklund, KE; Transbøl, I | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Jensen, J; Stocklund, KE; Transbøl, I | 1 |
| Ahmed, AI; Crook, D; Fogelman, I; Proudler, AJ; Rymer, JM; Stevenson, JC | 1 |
| Henkin, Y; Niv, Y | 1 |
| Graff-Iversen, S; Stensvold, I; Tverdal, A | 1 |
| Barnes, JF; Brown, A; Calder, A; Farish, E; Fletcher, CD; Hart, DM; Spowart, K | 1 |
| Connell, JM; Hillier, C; Lowe, GD; Lumsden, MA; Perera, M; Petrie, JR; Sattar, N; Small, M | 1 |
| Christiansen, C; Haarbo, J; Hansen, BF | 1 |
| Gambrell, RD | 1 |
| Ellis, JW | 1 |
| Lange, RL; Maleki, M | 1 |
2 review(s) available for norethindrone and Coronary Disease
| Article | Year |
|---|---|
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
Multiphasic oral contraceptives. Efficacy and metabolic impact.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Cerebrovascular Disorders; Contraceptives, Oral, Combined; Coronary Disease; Endometrium; Estradiol Congeners; Female; Humans; Menstrual Cycle; Norethindrone; Pregnancy; Progesterone; Progesterone Congeners | 1987 |
9 trial(s) available for norethindrone and Coronary Disease
| Article | Year |
|---|---|
Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Topics: Adult; Age Factors; Coronary Disease; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Risk Factors; Serine Endopeptidases | 2010 |
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.
Topics: Aged; Biomarkers; Blood Coagulation; Coronary Disease; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Estradiol; Factor VII; Feasibility Studies; Female; Fibrinolysis; Hemostasis; Hormone Replacement Therapy; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Pilot Projects | 2006 |
Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
Topics: Administration, Cutaneous; Age Factors; Aged; Aged, 80 and over; Aging; Blood Flow Velocity; Brachial Artery; Chi-Square Distribution; Coronary Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endothelium, Vascular; Estradiol; Female; Humans; Middle Aged; Multivariate Analysis; Nitroglycerin; Norethindrone; Norethindrone Acetate; Postmenopause; Probability; Reference Values; Risk Factors; Treatment Outcome; Vascular Patency | 2007 |
Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
Topics: Calcium; Coronary Disease; Drug Therapy, Combination; Estradiol; Estriol; Female; Hormones; Humans; Menopause; Norethindrone; Osteoporosis; Risk | 1984 |
[Effects of natural estrogen/gestagen and thiazide on cardiovascular risk factors in normal menopausal women. A 2-year double-blind placebo study].
Topics: Adult; Bendroflumethiazide; Coronary Disease; Double-Blind Method; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Placebos | 1981 |
Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norethindrone; Postmenopause; Risk Factors; Triglycerides | 1996 |
The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
Topics: Administration, Cutaneous; Blood Coagulation Factors; Cholesterol; Cholesterol, HDL; Coronary Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Lipoproteins; Middle Aged; Norethindrone; Placebos; Postmenopause; Triglycerides; von Willebrand Factor | 2001 |
Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Cholesterol; Coronary Disease; Diet; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Rabbits | 1991 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
9 other study(ies) available for norethindrone and Coronary Disease
| Article | Year |
|---|---|
Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women.
Topics: Adult; Cardiovascular Diseases; Cause of Death; Coronary Disease; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norway; Regression Analysis | 2004 |
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
Topics: Aged; Breast Neoplasms; Cohort Studies; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Levonorgestrel; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2006 |
Effect on lipoproteins of Trisequens, a combined hormone preparation.
Topics: Adult; Castration; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipoproteins; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Risk; Triglycerides | 1984 |
Effects of progestogens on the cardiovascular system.
Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Coronary Disease; Estrogens; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins | 1982 |
Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study.
Topics: Adult; Bendroflumethiazide; Blood Glucose; Blood Pressure; Body Weight; Coronary Disease; Double-Blind Method; Estrenes; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone | 1981 |
Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women.
Topics: Coronary Disease; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Peptidyl-Dipeptidase A; Postmenopause; Prospective Studies; Risk Factors | 1995 |
Estrogen-progestin therapy and coronary heart disease in radiation-induced rectal telangiectases.
Topics: Aged; Aged, 80 and over; Coronary Disease; Estradiol Congeners; Ethinyl Estradiol; Gastrointestinal Hemorrhage; Humans; Male; Norethindrone; Progesterone Congeners; Prostatic Neoplasms; Radiation Injuries; Rectal Diseases; Rectum; Telangiectasis | 1995 |
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1996 |
Coronary thrombosis in young women on oral contraceptives: report of two cases and review of the literature.
Topics: Adult; Cardiac Catheterization; Cineangiography; Contraceptives, Oral; Coronary Disease; Electrocardiography; Female; Humans; Mestranol; Myocardial Infarction; Norethindrone; Norethynodrel; Thrombosis | 1973 |